Author

Leila J. Williams

ORCID 0000-0002-9833-859XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

Anja F. Hohmann· 1 shared Caroline Bullock· 1 shared Caroline Dugopolski· 1 shared Christopher Wrocklage· 1 shared Conor Calnan· 1 shared Fiona A. Sharp· 1 shared Frank P. StegmeieriD· 1 shared Frank ThompsoniD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anja F. Hohmann

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyJournal of Clinical InvestigationPeer-reviewedDec 14, 2023

Rational design of a SOCS1-edited tumor infiltrating lymphocyte therapy for solid tumors using CRISPR/Cas9 screens

Michael R. Schlabach, Sharon Lin, Zachary R. Collester…·Micah J. Benson

This study uses CRISPR/Cas9 screens to identify SOCS1 as a target for enhancing T cell therapy, leading to the development of an engineered TIL therapy with improved anti-tumor function.

45 citationstop 3%

mousegenetic perturbation / CRISPR

𝕏 PostBluesky